What is ABTI stock price today?

Visit our real-time dashboard for the current ABTI stock price and live market data.

Is ABTI stock going up or down today?

ABTI stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ABTI stock now?

The decision to buy ABTI depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ABTI a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ABTI based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ABTI stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ABTI is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ABTI's P/E ratio?

P/E ratio data for ABTI will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ABTI's market cap?

ABTI (Alterola Biotech Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is ABTI's price to book ratio?

ABTI trades at a price-to-book (P/B) ratio of 0.52, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ABTI pay dividends?

ABTI does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ABTI's dividend yield?

ABTI does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ABTI stock a good long-term investment?

ABTI's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ABTI's revenue growth rate?

Revenue growth data for ABTI is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ABTI are available on our dashboard with complete income statement analysis.

What are the risks of investing in ABTI?

Key risks for ABTI include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ABTI compare to its competitors?

Compare ABTI to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ABTI's performance and positioning.

What is ABTI's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ABTI with bull, base, and bear case scenarios.

What do analysts say about ABTI?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ABTI. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ABTI's next earnings report?

ABTI reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ABTI - Alterola Biotech Inc

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$0.00

+$0.00 (+0.00%)

About Alterola Biotech Inc

Alterola Biotech Inc (ABTI) common stock

Price Chart

Loading chart...

ABTI Key Statistics

Market Cap

$7.44M

P/B Ratio

0.52

How ABTI Compares to Peers

ABTI is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ABTI(This stock)	$7.44M	N/A	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 20, 2026 at 3:11 PM EDT

Ready to invest in ABTI?

Commission-free trading available. Affiliate links.

ABTI Lician Score

5% confidence

4.0/10

Neutral

ABTI has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ABTIacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ABTI Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ABTI

Dashboard

Enter a ticker to analyze